Live Analyst Rating Changes 54325 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Daniel Arias
STIF

Daniel Arias

Stifel Nicolaus
Wall Street Analyst
★★★★★
#29
on 13Foresight · ranked by our own returns
73%
Success Rate
+12.2%
Average Return
45 of 62 calls profitable · +11.5% vs benchmark
S&P 500 (SPY)
🔒 3-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 73% of Daniel Arias's ratings turned a profit when each position was held for 1 year — averaging +12.2% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

73 Buy 33 Hold 0 Sell
Daniel's Stock Coverage 24 ratings · 2026-11-06
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
ILMN
Illumina
 Oct 30, 2026 BUY Buy
-10.0% avg upside
32 analysts
$300.00
27.20% Upside
 -9.8% ·
AVTR
Avantor
 Oct 29, 2026 HOLD Buy
+4.5% avg upside
27 analysts
$18.00
12.06% Upside
 -9.2% ·
RGEN
Repligen
 Oct 28, 2026 BUY Strong Buy
+1.2% avg upside
25 analysts
$207.00
16.96% Upside
 -6.1% ·
TMO
Thermo Fisher
 Oct 22, 2026 BUY Strong Buy
-5.2% avg upside
40 analysts
$775.00
11.18% Upside
 +4.4% ·
DHR
Danaher
 Oct 22, 2026 BUY Strong Buy
-4.4% avg upside
47 analysts
$260.00
11.91% Upside
 +0.2% ·
A
Agilent
 Aug 30, 2026 BUY Strong Buy
-8.1% avg upside
35 analysts
$180.00
3.00% Upside
 +14.0% ·
MXCT
MaxCyte
 Aug 13, 2026 BUY Strong Buy
+151.7% avg upside
5 analysts
$4.00
151.65% Upside
 -9.3% ·
MASS
908 Devices
 Aug 12, 2026 BUY Strong Buy
+11.1% avg upside
5 analysts
$12.00
6.67% Upside
 +1.9% ·
QGEN
Qiagen
 Aug 11, 2026 HOLD Buy
-10.5% avg upside
25 analysts
$40.00
20.33% Downside
 +19.2% ·
TXG
10x Genomics
 Aug 11, 2026 BUY Buy
-7.5% avg upside
19 analysts
$50.00
28.61% Downside
 +0.1% ·
MRVI
Maravai Lifesciences Holdings
 Aug 11, 2026 BUY Strong Buy
+99.6% avg upside
18 analysts
$8.00
2.46% Upside
 +20.1% ·
ALMR
Alamar Biosciences, Inc.
 Aug 11, 2026 BUY Strong Buy
+9.1% avg upside
5 analysts
$32.00
4.59% Upside
 -17.4% ·
RPID
Rapid Micro Biosystems
 Aug 10, 2026 BUY Strong Buy
+1089.0% avg upside
6 analysts
$8.00
987.07% Upside
 -59.5% ·
BLLN
BillionToOne, Inc. Class A
 Aug 06, 2026 BUY Strong Buy
+12.2% avg upside
10 analysts
$145.00
27.99% Upside
 +24.3% ·
BRKR
Bruker
 Aug 05, 2026 HOLD Buy
+4.9% avg upside
22 analysts
$50.00
12.35% Downside
 +10.7% ·
WAT
Waters
 Aug 05, 2026 HOLD Strong Buy
-12.6% avg upside
31 analysts
$420.00
9.24% Downside
 +14.9% ·
RVTY
Revvity
 Aug 05, 2026 HOLD Buy
-20.0% avg upside
25 analysts
$110.00
30.02% Downside
 +34.9% ·
TEM
Tempus AI, Inc. Class A
 Aug 03, 2026 HOLD Buy
-0.3% avg upside
25 analysts
$50.00
30.71% Downside
 +63.2% ·
GH
Guardant Health
 Aug 03, 2026 BUY Strong Buy
-3.1% avg upside
33 analysts
$180.00
0.73% Upside
 -5.0% ·
MTD
Mettler-Toledo
 Aug 03, 2026 BUY Buy
-26.0% avg upside
19 analysts
$1600.00
4.51% Downside
 +19.3% ·
TECH
Bio-Techne
 May 07, 2026 HOLD Hold
+16.2% avg upside
21 analysts
$50.00
31.12% Downside
 +43.1% ·
CDXS
Codexis
 Nov 10, 2025 BUY Strong Buy
+746.3% avg upside
13 analysts
$5.00
320.14% Upside
 -38.9% ·
ABSI
AbSci
 Jan 22, 2025 HOLD Strong Buy
+20.1% avg upside
20 analysts
 — -21.6% ·
RNLXY
Renalytix
 Mar 01, 2024 BUY Strong Buy
+190.7% avg upside
5 analysts
$5.00
35.26% Upside
 · ·
🔒 19 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Daniel Arias — Frequently Asked Questions
How accurate are Daniel Arias's stock ratings?
Based on the calls 13Foresight could measure, about 74% of Daniel's ratings were profitable over a one-year hold, with an average return of +12.3% per rating, or +10.2% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Daniel ranked on 13Foresight?
Daniel Arias is currently ranked #29 with a 5-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Daniel cover?
Daniel most recently has ratings on ILMN, AVTR, RGEN, TMO, DHR, A, MXCT, MASS, QGEN, TXG, MRVI, ALMR and 12 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.